| Specific effects of microRNAs on the plant transcriptome R Schwab, JF Palatnik, M Riester, C Schommer, M Schmid, D Weigel Developmental cell 8 (4), 517-527, 2005 | 1703 | 2005 |
| Highly Specific Gene Silencing by Artificial MicroRNAs in Arabidopsis R Schwab, S Ossowski, M Riester, N Warthmann, D Weigel The Plant Cell 18 (5), 1121-1133, 2006 | 1655 | 2006 |
| Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ... Nature medicine 24 (10), 1504-1506, 2018 | 480 | 2018 |
| Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito, K Helmy, N Charles, ... Cancer cell 26 (2), 288-300, 2014 | 426 | 2014 |
| JAK–STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response M Kleppe, M Kwak, P Koppikar, M Riester, M Keller, L Bastian, T Hricik, ... Cancer discovery 5 (3), 316-331, 2015 | 306* | 2015 |
| Pharmacogenomic agreement between two cancer cell line data sets Cancer Cell Line Encyclopedia Consortium, ... Nature 528 (7580), 84-87, 2015 | 283 | 2015 |
| Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples M Riester, W Wei, L Waldron, AC Culhane, L Trippa, E Oliva, S Kim, ... Journal of the National Cancer Institute, dju048, 2014 | 223 | 2014 |
| Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer M Riester, JM Taylor, A Feifer, T Koppie, JE Rosenberg, RJ Downey, ... Clinical cancer research 18 (5), 1323-1333, 2012 | 221 | 2012 |
| Evolution of the cancer genome O Podlaha, M Riester, S De, F Michor Trends in Genetics 28 (4), 155-163, 2012 | 207 | 2012 |
| curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome BF Ganzfried, M Riester, B Haibe-Kains, T Risch, S Tyekucheva, I Jazic, ... Database 2013, 2013 | 204 | 2013 |
| Molecular alterations and everolimus efficacy in human epidermal growth factor receptor 2–overexpressing metastatic breast cancers: combined exploratory biomarker analysis from … F André, S Hurvitz, A Fasolo, LM Tseng, G Jerusalem, S Wilks, R O’Regan, ... Journal of Clinical Oncology 34 (18), 2115-2124, 2016 | 176 | 2016 |
| FRANz: reconstruction of wild multi-generation pedigrees M Riester, PF Stadler, K Klemm Bioinformatics 25 (16), 2134-2139, 2009 | 139 | 2009 |
| Aberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity S De, R Shaknovich, M Riester, O Elemento, H Geng, M Kormaksson, ... PLoS genetics 9 (1), e1003137, 2013 | 134 | 2013 |
| Tracking the evolution of resistance to ALK tyrosine kinase inhibitors through longitudinal analysis of circulating tumor DNA I Dagogo-Jack, AR Brannon, LA Ferris, CD Campbell, JJ Lin, KR Schultz, ... JCO precision oncology 2, 1-14, 2018 | 131 | 2018 |
| PureCN: copy number calling and SNV classification using targeted short read sequencing M Riester, AP Singh, AR Brannon, K Yu, CD Campbell, DY Chiang, ... Source code for biology and medicine 11, 1-13, 2016 | 130 | 2016 |
| TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts AL Grauel, B Nguyen, D Ruddy, T Laszewski, S Schwartz, J Chang, ... Nature communications 11 (1), 6315, 2020 | 126 | 2020 |
| Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer L Waldron, B Haibe-Kains, AC Culhane, M Riester, J Ding, XV Wang, ... Journal of the National Cancer Institute 106 (5), dju049, 2014 | 125 | 2014 |
| Cross-study validation for the assessment of prediction algorithms C Bernau, M Riester, AL Boulesteix, G Parmigiani, C Huttenhower, ... Bioinformatics 30 (12), i105-i112, 2014 | 113 | 2014 |
| Software for the integration of multiomics experiments in bioconductor M Ramos, L Schiffer, A Re, R Azhar, A Basunia, C Rodriguez, T Chan, ... Cancer research 77 (21), e39-e42, 2017 | 102 | 2017 |
| Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features JJ Pitt, M Riester, Y Zheng, TF Yoshimatsu, A Sanni, O Oluwasola, ... Nature communications 9 (1), 4181, 2018 | 101 | 2018 |
Franziska MichorAssociate Professor of Biostatistics, Harvard University在 jimmy.harvard.edu 的电子邮件经过验证
